logo

Immunic, Inc (IMUX)



Trade IMUX now with
  Date
  Headline
6/15/2020 6:31:53 AM Immunic Announces First Patients Dosed In Phase 2, CALVID-1 Clinical Trial Of IMU-838 In COVID-19
6/10/2020 9:20:05 AM Immunic Prices $25 Mln Public Offering Of Common Stock
6/9/2020 7:04:07 AM Immunic Announces FDA Allowance Of Phase 2, CALVID-1 Clinical Trial Of IMU-838 In COVID-19
5/8/2020 6:35:47 AM Immunic Q1 Net Loss $8.5 Mln Or $0.79/shr Vs. Net Loss $4.3 Mln Or $5.09/shr Last Year
4/23/2020 9:06:17 AM Immunic Reports Pricing Of $15 Mln Financing
12/4/2019 6:33:36 AM Immunic Plans To Present Data On IMU-856 At IBD Innovate Conference
10/15/2019 6:33:27 AM Immunic Appoints Tamar Howson To Board Of Directors
9/18/2019 6:32:26 AM Immunic Doses First Healthy Volunteer In Its Phase 1 Clinical Program Of IMU-935
8/12/2019 6:36:43 AM Immunic Announces First Patient Enrolled In Proof-of-Concept Clinical Trial Of IMU-838
8/8/2019 6:39:18 AM Immunic Q2 Net Loss $14.7 Mln Or $1.52/shr Vs. Loss $2.7 Mln Or $3.15/shr Prior Year
7/16/2019 6:34:13 AM Immunic Appoints Sanjay Patel As CFO